Viewing Study NCT02909166


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-02-26 @ 2:18 AM
Study NCT ID: NCT02909166
Status: UNKNOWN
Last Update Posted: 2016-09-21
First Post: 2016-09-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF.
Sponsor: Mika Lehto
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-01
Start Date Type: None
Primary Completion Date: 2016-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2017-12
Completion Date Type: ESTIMATED
First Submit Date: 2016-09-16
First Submit QC Date: None
Study First Post Date: 2016-09-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-09-20
Last Update Post Date: 2016-09-21
Last Update Post Date Type: ESTIMATED